Posted on May 28, 2014
Amgen recently announced that the FDA has approved the use of Vectibix as a first-line treatment for colorectal cancer. Since 2006, Vectibix has been used as a second-line treatment and with this recent advancement, colorectal cancer patients now have an additional treatment option earlier in their diagnosis. Read more
Posted on May 6, 2014
According to the American Cancer Society (ACS), colorectal cancer is the third leading cause of cancer death in the U.S. The ACS estimates nearly 137,000 Americans will be diagnosed with the disease this year and more than 50,000 will die from it.
Knowing these statistics, it is more important than ever to act as your own healthcare advocate when it comes to a colorectal cancer diagnosis. While it’s true that your physician has your best interests in mind, nobody knows your body as well as you do. By acknowledging your body’s warning signs and staying informed about the latest healthcare developments, you can help prevent yourself from becoming another colorectal cancer statistic. Read more
Posted on April 25, 2014
Scientific research is among the best ways we can go on the offensive against colon cancer. That’s why we’ve launched the Blue Hope Research Award, a one-year fellowship providing vital resources and funding to a bright investigator interested in making his mark in the colon cancer space. This year, we utilized the American Association for Cancer Research peer-review process to select a scientist who is taking a deeper look at biomarkers associated with treatment of colon cancer. We’re honored to introduce Marios Giannakis, M.D., Ph.D., our first-ever Blue Hope Research Awardee. Learn more about the research he’s working on and what it means for you! Read more
Posted on March 11, 2014
Medicine, specifically cancer treatment, is different than it was 10 years ago. The growing use of digital technology has helped build communities and increase access to information, offering cancer patients the tools to become their own advocates. Read more
Posted on January 14, 2014
Here’s a startling fact: Cancer survivors are more likely to NOT get recommended screening for other cancers.
You would think that cancer survivors would be the first in line to be screened for other cancers. But oftentimes, this isn’t the case. As patients and their doctors become so focused on and busy with fighting their current cancer, post-checkups and recurrences that screening for a second cancer often gets overlooked. Read more